Affordable Access

Meeting report: targeting the kinome—20 years of tyrosine kinase inhibitor research in Basel.

Authors
Type
Published Article
Journal
Science s STKE
Publisher
American Association for the Advancement of Science (AAAS)
Volume
2007
Issue
374
Source
Hunter Lab
License
Unknown

Abstract

With basic and pharmaceutical researchers, chemists, pharmacologists, and clinicians, the Targeting the Kinome meeting brought together a tremendous group of scientists to discuss the past, present, and future of protein kinase research, with a special emphasis on cancer therapy development. The topics ranged from the kinases themselves as drug targets through the interactions that the actions of these enzymes promote, to the physiological and pathological processes they regulate. Attendees gained insight into drug development, as well as increased understanding of how normal cellular processes are subverted during oncogenesis, which may lead to new targets for intervention.

Report this publication

Statistics

Seen <100 times